Immunovant
IMVT
IMVT
133 hedge funds and large institutions have $980M invested in Immunovant in 2022 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 53 increasing their positions, 28 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
89% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 28
19% more funds holding
Funds holding: 112 → 133 (+21)
7.16% more ownership
Funds ownership: 36.59% → 43.75% (+7.2%)
Holders
133
Holding in Top 10
5
Calls
$8.87M
Puts
$246K
Top Buyers
| 1 | +$55.9M | |
| 2 | +$45.5M | |
| 3 | +$44.2M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$39.7M |
| 5 |
CAC
Cowen and Company
New York
|
+$22.2M |
Top Sellers
| 1 | -$50.6M | |
| 2 | -$29.8M | |
| 3 | -$27.2M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$16.8M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$4.4M |